(Q47698255)

4 February 2018

title

Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty (English)

1 reference

4 February 2018

author name string

van der Heide HJ

1

1 reference

4 February 2018

Koorevaar RT

2

1 reference

4 February 2018

Schreurs BW

3

1 reference

4 February 2018

van Kampen A

4

1 reference

4 February 2018

Lemmens A

5

1 reference

4 February 2018

publication date

1 October 1999

1 reference

4 February 2018

published in

Journal of Arthroplasty

1 reference

4 February 2018

volume

14

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

796-799

1 reference

4 February 2018

Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Indomethacin for prevention of ectopic ossification after hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Effect of ibuprofen on heterotopic ossification after hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2899%2990027-X

7 January 2021

10.1016/S0883-5403(99)90027-X

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018